US halts use of GSK/Vir mon­o­clon­al in 8 states as FDA says it can't de­feat new Omi­cron sub­vari­ant

With the emer­gence of the new but not nec­es­sar­i­ly more dan­ger­ous Omi­cron sub­vari­ant BA.2, the FDA on Fri­day an­nounced that Glax­o­SmithK­line and Vir’s block­buster mon­o­clon­al …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER